Speaker Profile

M.D., ITOR Medical Director, Greenville Health System

Dr. Edenfield earned his medical degree from the University of Miami, Florida. He completed his internship, residency and fellowship at Walter Reed Army Medical Center in Washington, DC, where he received the Bailey K. Ashford Research Medal. Dr. Edenfield also completed a research fellowship in Hematologic Malignancy at Johns Hopkins University School of Medicine in Baltimore, Maryland. He served as Chief of Oncology at Womack Army Medical Center in North Carolina. He is a diplomat of the boards of internal medicine, medical oncology, and hematology. He is also board certified by the American Association of Hospice and Palliative Care Medicine in palliative care. Dr. Edenfield has published his works in a number of leading scientific journals. Currently Dr. Edenfield serves as Medical Director of ITOR, Chair of the Division of Oncology at the GHS Cancer Institute, and holds the appointment of Clinical Associate Professor in Hematology/Oncology Division of Internal Medicine, USC School of Medicine.

Session Abstract

Session Synopsis: The impact of precision medicine in oncology is undeniable. Precision diagnosis and treatment of cancer at the molecular level has profound implications on the outcome, but requires physician awareness, understanding, and adoption to deliver successful personalized treatment for cancer patients. This session will share the challenges to create a process for organizational and physician engagement while they incorporate precision oncology into practice.